Haifeng Wan
- Civil and Structural Engineering top 10%
- Molecular Biology
- Hepatology top 10%
- Cancer Research
- Oncology
- Co-authors
- Lei GaoHui QuManman SuHong WuKunlin XieHao ChengXiaoqiang ChenKefei Yuan
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Ferroptosis and cancer prognosis (3 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Haifeng Wan
25 papers receiving 372 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Civil and Structural Engineering 104
- Molecular Biology 64
- Hepatology 59
- Cancer Research 46
- Oncology 44
Countries citing papers authored by Haifeng Wan
This map shows the geographic impact of Haifeng Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Wan more than expected).
Fields of papers citing papers by Haifeng Wan
This network shows the impact of papers produced by Haifeng Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Wan. The network helps show where Haifeng Wan may publish in the future.
Co-authorship network of co-authors of Haifeng Wan
This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Wan. A scholar is included among the top collaborators of Haifeng Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Wan. Haifeng Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironmentbreakdown → | 24 |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 17 | |
| 6 | 3 | |
| 7 | 11 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 12 | |
| 13 | 19 | |
| 14 | 34 | |
| 15 | 4 | |
| 16 | 40 | |
| 17 | 11 | |
| 18 | 22 | |
| 19 | 5 | |
| 20 | 4 |
About Haifeng Wan
Haifeng Wan is a scholar working on Hepatology, Cancer Research and Geriatrics and Gerontology, having authored 26 papers that have together received 378 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Ferroptosis and cancer prognosis (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Hepatology (59 citations), Civil and Structural Engineering (104 citations) and Cancer Research (46 citations). Haifeng Wan has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Lei Gao, Hui Qu, Manman Su, Hong Wu, Kunlin Xie, Hao Cheng, Xiaoqiang Chen, Kefei Yuan, Tian Lan and Xiaokai Yan. Their work appears in journals such as Nature Communications, Construction and Building Materials and Expert Systems with Applications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.